Menu
Search
|

Menu

Close
X

Getein Biotech Inc 603387.SS (Shanghai Stock Exchange)

25.02 CNY
-1.29 (-4.90%)
As of 8:00 AM BST
Previous Close 26.31
Open 26.31
Volume 3,410,977
3m Avg Volume 4,445,505
Today’s High 26.31
Today’s Low 24.85
52 Week High 39.86
52 Week Low 18.24
Shares Outstanding (mil) 260.42
Market Capitalization (mil) 6,851.59
Forward P/E 25.60
Dividend (Yield %) 0.29 ( 1.11 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, CNY)
FY19
207
FY18
686
FY17
489
FY16
369
EPS (CNY)
FY19
0.329
FY18
0.957
FY17
0.878
FY16
1.024
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
25.60
34.10
Price to Sales (TTM)
vs sector
9.15
7.99
Price to Book (MRQ)
vs sector
4.75
4.39
Price to Cash Flow (TTM)
vs sector
--
24.00
Total Debt to Equity (MRQ)
vs sector
2.79
17.94
LT Debt to Equity (MRQ)
vs sector
0.00
12.82
Return on Investment (TTM)
vs sector
20.39
12.64
Return on Equity (TTM)
vs sector
20.27
17.18

EXECUTIVE LEADERSHIP

Enben Su
Chairman of the Board, General Manager, Since
Salary: --
Bonus: --
Wen Ni
Chief Financial Officer, Since
Salary: --
Bonus: --
Binbin Yan
Deputy General Manager, Secretary of the Board, Director, Since
Salary: --
Bonus: --
Bin Li
Director, Since
Salary: --
Bonus: --
Enkui Su
Director, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

NANJING   JNG   211505

Phone: +8625.68568577

Getein Biotech, Inc. is a China-based company principally engaged in the research and development, production and sales of in vitro diagnostic products. The Company's main products include point-of-care testing (POCT) in vitro diagnostic reagents and ancillary equipment. The Company is also engaged in the production and sales of biochemical latex in vitro diagnostic reagents. The Company mainly operates its businesses in East China, Central China, North China and Southwest region.

SPONSORED STORIES